These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 392482)

  • 1. The effect of flucytosine on the germination of Candida albicans.
    Wain WH; Polak A
    Postgrad Med J; 1979 Sep; 55(647):671-3. PubMed ID: 392482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of 5-fluorocytosine.
    Waldorf AR; Polak A
    Antimicrob Agents Chemother; 1983 Jan; 23(1):79-85. PubMed ID: 6338821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 5-fluorocytosine on the blastospores and hyphae of Candida albicans.
    Polak A; Wain WH
    J Med Microbiol; 1979 Feb; 12(1):83-97. PubMed ID: 372535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
    Slim A; Bergogne-Berezin E; Courtoux D
    Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 5-fluorocytosine on the temperature profile of Candida albicans.
    Lemos-Carolino M; Madeira-Lopes A
    Sabouraudia; 1984; 22(4):351-4. PubMed ID: 6390737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5-fluorocytosine on protein synthesis and amino acid pool in Candida albicans.
    Polak A
    Sabouraudia; 1974 Nov; 12(3):309-19. PubMed ID: 4610823
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for sequential action of amphotericin B and 5-fluorocytosine on Canida albicans ATCC 11651.
    Beggs WH; Andrews FA; Sarosi GA
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):557-60. PubMed ID: 322227
    [No Abstract]   [Full Text] [Related]  

  • 8. Complementation analysis of resistance to 5-fluorocytosine in Candida albicans.
    Whelan WL; Markie D; Kwon-Chung KJ
    Antimicrob Agents Chemother; 1986 May; 29(5):726-9. PubMed ID: 3524427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations on 5-fluorocytosine and Candida albicans.
    Davies RR; Savage MA
    Sabouraudia; 1974 Nov; 12(3):302-8. PubMed ID: 4610822
    [No Abstract]   [Full Text] [Related]  

  • 10. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans].
    Rumler W; Heins S
    Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290
    [No Abstract]   [Full Text] [Related]  

  • 11. Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. II. Studies on distribution and incorporation.
    Polak A; Scholer HJ
    Pathol Microbiol (Basel); 1973; 39(5):334-7. PubMed ID: 4580714
    [No Abstract]   [Full Text] [Related]  

  • 12. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
    Beggs WH; Sarosi GA
    Chemotherapy; 1982; 28(5):341-4. PubMed ID: 6754278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of 5-fluorocytosine on nucleic acid synthesis in Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.
    Polak A; Wain WH
    Chemotherapy; 1977; 23(4):243-59. PubMed ID: 324722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action of 5-fluorocytosine.
    Diasio RB; Bennett JE; Myers CE
    Biochem Pharmacol; 1978 Mar; 27(5):703-7. PubMed ID: 350227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sensitivity of Candida strains to selected antifungal antibiotics].
    Jurek M; Dzierzanowska D
    Pol Tyg Lek; 1984 Sep; 39(38):1269-71. PubMed ID: 6390387
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine.
    Persson M; Winblad B; Anséhn S; Schönebeck J
    Scand J Infect Dis; 1978; 10(1):87-90. PubMed ID: 345424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Segregation of 5-fluorocytosine-resistance variants by Candida albicans.
    Whelan WL; Beneke ES; Rogers AL; Soll DR
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1078-81. PubMed ID: 7023383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [C. albicans spontaneous mutations determining 5-fluorocytosine resistance].
    Pawlik B; Barylak J
    Med Dosw Mikrobiol; 1977; 29(4):301-7. PubMed ID: 340821
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relation between the antibiotic concentration and contact time of the effect of 5-fluorocytosine, bifonazole and Bay N 7133 on Candida albicans].
    Rumler W; Heins S; Heins J
    Mykosen; 1984 Sep; 27(9):436-42. PubMed ID: 6390193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.